Stephen Joyce
Public Communications Contact at AMRYT PHARMA PLC
Stephen Joyce active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AMRYT PHARMA PLC | Public Communications Contact | - | - |
| Sales & Marketing | - | - |
Career history of Stephen Joyce
Former positions of Stephen Joyce
| Companies | Position | Start | End |
|---|---|---|---|
| Astellas Pharmaceuticals AG | Corporate Officer/Principal | 2017-12-31 | 2018-10-31 |
Astellas Pharma Europe Ltd.
 Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Corporate Officer/Principal | 2016-03-31 | 2017-12-31 |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Public Communications Contact | - | - |
| Sales & Marketing | - | - |
Training of Stephen Joyce
| Trinity College Dublin | Undergraduate Degree |
Statistics
International
| United Kingdom | 4 |
| Ireland | 2 |
| Switzerland | 2 |
Operational
| Public Communications Contact | 2 |
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
| Astellas Pharmaceuticals AG | |
Amryt Pharma Plc
 Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Stephen Joyce
- Experience
